… More than 60% of patients diagnosed with squamous cell carcinoma of the head and
neck present at a locally advanced stage. Although multimodality therapy has improved …

… Standard treatment for locally advanced head and neck squamous cell carcinoma (… Rational
and standard induction Induction chemotherapy can eradicate micro metastases and thus …

… carcinoma to three cycles of PF induction chemotherapy followed by locoregional treatment,
or to locoregional treatment (radiation therapy + surgery) alone [12]. The response rate to …

… The induction chemotherapy regimen was administered over 3 cycles and was followed …
induction chemotherapy died during the first year of treatment (2 during induction chemotherapy…

… Over the last 30 years, induction chemotherapy has attained an important … cell carcinoma,
particularly since the introduction of taxanes. The decision to deliver induction chemotherapy (…

… Several new induction chemotherapy treatment developments are currently underway, and
… position of induction chemotherapy for head and neck squamous cell carcinoma, based on …

… use of induction chemotherapy in the setting of locally advanced disease—both resectable
and unresectable. In this review we summarise data for the use of induction chemotherapy to …

… evolved was the use of induction or neoadjuvant chemotherapy. The rationale for …
chemotherapy seen in the previously untreated patient and the possibility that chemotherapy-induced …

… To standardize staging procedures, the same surgeon, radiotherapist, and medical oncologist
saw all patients, both initially and following induction chemotherapy Our approach was to …

… to remove the lesions completely after induction chemotherapy, especially in the patients …
induction chemotherapy in patients with resectable head and neck squamous cell carcinoma…